Nautilus Biotechnology (NASDAQ:NAUT) reported third-quarter revenue of $200,000 as it continued its transition toward ...

Biotechnology is a broad discipline in which biological processes, organisms, cells or cellular components are exploited to develop new technologies. New tools and products developed by ...

According to BCC Research, the global agricultural biotechnology market is projected to grow from $91.5 billion in 2026 to ...

Moderna gave investors a scare as its stock plunged on Thursday. But it's still one of the hottest biotechs this year. And it's hardly alone – the sector is on a roll and looks poised for more gains.

Nautilus Biotechnology, Inc. reported its financial results for the third quarter ended September 30, 2026. Revenue was $0.2 million for the third quarter of 2026, primarily driven by grant revenue ...

Golden Age Health is co-founded and chaired by Michel Vounatsos, former Biogen CEO and Merck President NEW YORK and ATHENS, Greece and SINGAPORE, Oct. 26, 2026 /PRNewswire/ -- Kos Biotechnology ...

Vir Biotechnology is approaching multiple clinical readouts from drugs with positive data previously. Click here to read an ...

Biotechnology firm INmune Bio Inc. (NASDAQ: INMB) and photonic quantum developer Quantum Computing Inc. (NASDAQ: QUBT) have ...

Biotechnology is a curious marriage of two seemingly disparate worlds. On one end, we have living organisms—wild, unpredictable celestial creations that can probably never be understood or appreciated ...

The Treasury Department’s proposed restrictions on U.S. investment in Chinese biopharma collide with Beijing’s new export ...

The Treasury Department is proposing rules to add biotechnology to its Outbound Investment Security Program under the COINS Act. The U.S. Department of the Treasury issued a Notice of Proposed ...

Stem cell biotechnology is a field of biotechnology that develops tools and therapeutics through modification and engineering of stem cells. Stem cell biotechnology is important in regenerative ...